Arterial stiffness, estimated by pulse wave velocity (PWV), is an independent predictor of cardiovascular mortality and morbidity. However, the clinical applicability of these measurements and the elaboration of reference PWV values are difficult due to differences between the various devices used. In a population of 50 subjects aged 20-84 years, we compared PWV measurements with three frequently used devices: the Complior and the PulsePen, both of which determine aortic PWV as the delay between carotid and femoral pressure wave and the PulseTrace, which estimates the Stiffness Index (SI) by analyzing photoplethysmographic waves acquired on the fingertip. PWV was measured twice by each device. Coefficient of variation of PWV was 12.3, 12.4 and 14.5% for PulsePen, Complior and PulseTrace, respectively. These measurements were compared with the reference method, that is, a simultaneous acquisition of pressure waves using two tonometers. High correlation coefficients with the reference method were observed for PulsePen (r ¼ 0.99) and Complior (r ¼ 0.83), whereas for PulseTrace correlation with the reference method was much lower (r ¼ 0.55). Upon Bland-Altman analysis, mean differences of values ± 2s.d. versus the reference method were À0.15 ± 0.62 m/s, 2.09 ± 2.68 m/s and À1.12±4.92 m/s, for PulsePen, Complior and PulseTrace, respectively. This study confirms the reliability of Complior and PulsePen devices in estimating PWV, while the SI determined by the PulseTrace device was found to be inappropriate as a surrogate of PWV. The present results indicate the urgent need for evaluation and comparison of the different devices to standardize PWV measurements and establish reference values.
Introduction
Viscoelastic properties of large arteries play an essential role in cardiovascular hemodynamics, especially in systolic blood pressure (SBP) determination. 1, 2 Certain physiological and pathological conditions such as age, hypertension and diabetes are responsible for a loss in arterial compliance. 3 Arterial stiffness, estimated by pulse wave velocity (PWV), has been shown to be an independent predictor of cardiovascular mortality and morbidity. 4, 5 The measurement of PWV is generally accepted as the simplest as well the most noninvasive, rapid and reproducible method for assessing large artery stiffness. [6] [7] [8] [9] Assessment of PWV may therefore play an important role in cardiovascular prevention and the evaluation of treatment efficacy [10] [11] [12] in addition to the fact that recent ESH-ESC recommendations indicate PWV measurement as a suitable exploration venue for use in clinical practice. 13 Pulse wave (PW) travels along the arteries at a velocity rate, which varies according to wall elasticity: the less elastic the wall, the higher the velocity of PW propagation. PWV measures the time of travel of the pressure wave over a known distance and is calculated as the distance between the two positions of the pulse transducer divided by the time delay measured between pressure upstroke at each site. Most commonly, PWV is recorded between carotid and femoral artery sites to provide a measure of aortic stiffness. The pressure wave can be recorded directly by means of force recorders, such as highfidelity applanation tonometers [14] [15] [16] [17] or by detecting arterial wall motion secondary to pulse pressure by means of mechanotransducers or ultrasonographic systems. [18] [19] [20] [21] [22] A surrogate of PWV, the stiffness index (SI), has also been proposed by assessing capillary consequences of arterial stiffness using photoplethysmography, although some studies have showed a feeble correlation between SI and carotid-femoral PWV (PWV cÀf ). [23] [24] [25] The calculation of propagation time can be measured by various means, including analyzing the foot of the pulse wave, the points of maximum upslope or peak-to-peak time.
The existence of several devices for the determination of PWV, using very different methods, renders the use of this parameter difficult in clinical practice, especially in the elaboration of proper reference values. To our knowledge, no comparison has been made yet between major assessment methods to evaluate the correspondence of obtained values, when one or another of these devices are used. In this study, three major noninvasive methods for assessing large artery stiffness were used and compared to a reference method.
Materials and methods
A population of 50 subjects (25 men and 25 women) aged 20-84 years (mean age: 49.3 ± 19.6 years) were recruited. To constitute homogeneously aged groups, subjects were evenly distributed according to age (from 20 to 79 years), with four individuals per each 5-year period being included. Two subjects older than 80 years of age were also included. Among the subjects recruited, 27 worked at the hospital and 23 were inpatients in our hospital. These inpatients were admitted for cardiovascular diseases (3), gastrointestinal disease (18), respiratory infection (1) and systemic disease (1) . Eight subjects were smokers; 11 subjects were hypertensive (BP 4140/90 in antihypertensive treatment); two inpatients were diabetic and seven subjects had dyslipidemia. Patients with cardiac arrhythmia were excluded from the study. The study protocol was approved by the Local Ethics Committee and conducted in accordance with the Helsinki Declaration. 26 Participants provided informed consent. Medical history, clinical examination and automatic BP assessment in supine position (Dinamap 1846 SX Critikon, JJM Inc. Arlington, TX, USA) were performed in all subjects. PWV was assessed in all 50 subjects using each of the four tested devices: Complior II, PulsePen, Pulse Trace PCA and the reference method. All testing was conducted in a quiet, temperature-controlled room. Subjects were asked to fast after having omitted any morning medication. Tests were initiated after a 15-min supine rest period. Estimation of PWV was performed in the following order: Complior II, PulseTrace PCA, reference method and PulsePen. Acquisition time was determined for all the tests. Testing was then repeated a second time in the same order. The four individual measurements obtained from each of the tested devices were carried out over different days at the same hour.
Reference method
The PWV cÀf is determined by the simultaneous acquisition of pressure waves using two highfidelity tonometers (Figure 1, upper panel) , considered as a 'reference method' test of arterial stiffness. 19 In this study, the time delay between the pulse waves was calculated using the 'foot-to-foot' method, determined as the mean of measured values on paper by two operators not directly involved in the acquisition phase. To this end, the carotid and femoral pressure waveforms were simultaneously recorded; the peripheral wave delay to the central wave was considered as the pressure wave progression time. Two tonometers provided by DiaTecne s.r.l., Milan were used. For assessment of the PW delay, the waves were printed on paper with a regular definition of 10 ms/mm for the time scale and a variable scale from 7 to 10 mm Hg/mm for pressure values. The units for the pressure value scale were dependent on the amplitude of the PW and were variable to record the pressure waveform on the entire height of the paper. The 'foot' of the pressure pulse waveform was determined by the intersection of the horizontal line tangent to the lowest point of the pressure waveform following the electrocardiogram complex with the extension of the line resulting from the initial protosystolic Pulse wave velocity estimation P Salvi et al rapid ascending phase of the pressure waveform. For the reference method as well as for Complior and PulsePen, the distance between the arterial points was assessed in a straight line, with a flexible meter, as the distance between the recording site at the femoral artery to the suprasternal notch minus the distance from the recording site at the carotid artery to the suprasternal notch, using a tapemeasure located at the same location as the probe. The PWV cÀf obtained with the reference method was compared with the respective PWV cÀf values obtained with the three different devices:
Complior II (Artec-medical, Pantin, France). This device, characterized by the simultaneous measurement of pressure pulses, employs dedicated mechanotransducers directly applied to the skin. The first operator begins positioning the probe at the common carotid artery, the central detection site, while a second operator places a second probe at the femoral artery site ( Figure 1 , upper panel). The sensor used to detect the pulse produces a signal, which is related to the derivative of the pressure pulse. A proprietary algorithm is then used to identify the waveform in the proximal and the peripheral artery to measure the time difference between the two sites and thereby to calculate the PWV from the distance between the two sites.
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PulsePen (DiaTecne s.r.l., Milan Italy). With this device, the delay between pressure wave is determined by a single high-fidelity applanation tonometer to obtain the carotid and femoral pulse recorded sequentially in highly rapid succession, using the electrocardiogram trace as reference ( Figure 1 , lower panel). The PulsePen device has been previously described in details. [27] [28] Herein, when the difference between heart rate recorded during the carotid measurement and that recorded during the femoral measurement was equal or greater than 10%, the PWV measurement was repeated (the difference in heart rate is indicated in the PulsePen software). According to this procedure, measurement of PWV had to be repeated in seven subjects.
PulseTrace PCA (Micro Medical Ltd, Rochester, UK). This device estimates the SI by analyzing the photoplethysmographic waves (digital volume pulse) acquired on the fingertip of the subject. 23 The determining form of SI is shown in Figure 2 .
All statistical analyses were performed using the NCSS Statistical software. Values are presented as the mean ± s.d. For each method, we first assessed variability and repeatability of PWV and PW transit time delay. The lack of agreement between the two measurements was estimated by the mean difference and the s.d. of the differences. Repeatability was assessed by calculating coefficient of variation (CV) for repeated measurements 29 and defined as the ratio of the s.d. of the between-measure difference to the overall mean expressed as percentage. Coefficient of repeatability, expressed as 2s.d. of differences, was also calculated.
Comparisons between the different methods were then realized. For that, mean values of the two measurements for each method were used. The results were analyzed in two steps according to the recommendations of Bland and Altman. 30 In the first step, the correlation between measurement values (equation of the linear relationship, correlation coefficient and P-value) was investigated. Secondly, the relative (positive or negative) differences within each pair of measurements were plotted against the mean of the pair to ensure that no obvious relationship appeared between the estimated value (mean) and the difference. Table 1 Measurements obtained by the two operators for the reference method (two tonometers), analyzing the same waves printed on paper were very similar: the mean difference in the carotid-femoral time Figure 2 The digital volume pulse obtained from an infrared sensor (photoplethysmography). Stiffness index is calculated as the height divided by the time delay between the first systolic peak and the early diastolic peak in the waveform.
Results
Pulse wave velocity estimation P Salvi et al delay ( ± s.d.) was 1.0 ± 1.9 ms, whereas the maximum difference between the two measurements was 4 ms. PWV mean difference was 0.18 ± 0.68 m/s.
All of the assessed methods were significantly correlated with age (Po0.001; Table 2 ). The correlations between PWV measured by the Complior and SBP and pulse pressure (PP ¼ SBP-DBP) were statistically significant (Po0.01); no significant correlation was shown between SBP and PP versus values obtained with either the PulseTrace, PulsePen or reference method.
In Figure Abbreviations: DBP, diastolic blood pressure; HR, heart rate; PP, pulse pressure; PWV, pulse wave velocity; SBP, systolic blood pressure. *Po0.01; **Po0.001. Pulse wave velocity estimation P Salvi et al
Discussion
In this study, a good correlation was found between aortic PWV values obtained with the devices based on measurements of the delay between carotid and femoral pressure pulse waves (PulsePen and Complior) and the reference method measured manually by the simultaneous use of two tonometers.
The PWV measured by the Complior device was significantly lower than the PWV measured by either PulsePen or reference method. PulsePen measures the carotid-femoral propagation time using the intersecting tangent algorithm to identify the foot of the waveform, while the Complior measures the propagation time from the point of maximum upstroke of the signal. In a previous report, Millasseau et al. 31 noted a significant difference between the Complior system and the intersecting tangent foot-to-foot algorithm used by the SphygmoCor (AtCor, Sydney, Australia) device. In their study, the PWV with the SphygmoCor was significantly greater than that of the Complior (mean difference ± s.d.; 0.91 ± 1.07 m/s; Po0.001), with the difference increasing with increasing PWV, that is, at a mean PWV of 12 m/s, the difference was 1.7±0.75 m/s (mean±s.d.). However, this difference was almost nullified when the intersecting tangent method was used to calculate the propagation time from the Complior waveforms. The PulsePen device tested herein utilizes the same method as the SphygmoCor. In the current study, we found similar results when comparing the Complior with the PulsePen as well as the Complior with the reference method. The difference was more pronounced in subject with higher PWV values. These results are in agreement with the conclusion of Millasseau et al. 31 that computation of PWV is critically dependent on the algorithm used to determine wave time delay in each device.
As we have shown in Figure 5 , the PW transit time delay is constantly higher with Complior as compared to the PW transit time delay measured by the reference method. The absolute value of this difference is about 20 ms and not influenced by the level of the transit time. This difference of 20 ms leads to an underestimation of PWV, which in relative value is more pronounced when the PWV is high, that is, when the transit time is lower. For example, in a subject with a PW transit time delay of 100 ms measured by the reference method and a distance between the two probes of 500 mm, PWV is calculated at 5 m/s. In this case, the time delay with Complior will be at 100 þ 20 ¼ 120 mms and the PWV is 4.1 m/s, that is, lower by 0.9 m/s. If now a patient with the same distance between the two probes has a PW transit time delay of 50 ms measured by the reference method, his PWV is calculated at 10 m/s. For this patient, adding 20 ms in the transit delay time (that is, from 50 to 70 ms) will lead to a PWV of 7.1 m/s, that is, a decrease in PWV by 2.9 m/s, which represents an almost 30% in PWV. These considerations can explain the In this study, we found a strong correlation between the reference method and the PulsePen (r ¼ 0.99) than between the reference method and the Complior (r ¼ 0.83). This difference can be explained by the fact that a tonometer was used for both the reference method and the PulsePen, whereas mechanotransducers were used for Complior measurements. In addition, the algorithm used by the PulsePen software to determine the foot of the pressure wave closely follows the method used by the two operators to detect the waveform foot printed on the paper. The strong relationship between the PulsePen and the reference method confirms that the use of a single tonometer measurement with the PulsePen provides almost identical values to that obtained with the manual reference method using two tonometers.
The time needed to perform the test with the PulsePen device was almost twice as long as with the PulseTrace and Complior devices. As the PWV is influenced by heart rate, the two-step measurement of aortic PWV with the PulsePen device always forces the operator to verify the heart rate difference during carotid and femoral measurements, and to repeat these measurements if the difference in heart rate between the two are elevated.
PulseTrace device is very easy to use and does not require specific training for the operators. This method is not dependent on adeptness or ability of operators, contrary to the PulsePen and Complior devices where specific training is necessary.
No significant correlation was found between PulseTrace SI and the reference method. Previously, Millasseau et al. 24 demonstrated a significant correlation between PWV determined by SphygmoCor and SI based on digital volume pulse waves (r ¼ 0.65, Po0.001) in a study performed on 84 seemingly healthy subjects under 68 years of age. In the Millasseau study, results from the BlandAltman analysis revealed that the difference in observed measurements between the two methods was upwards of 1 m/s in 44 subjects (51%) and upwards of 2 m/s in 20 subjects (23%). Similar data are also shown herein where 26% of the measurements by PulseTrace differed from the reference method by more than 2.0 m/s and 66% by more than 1.0 m/s. Therefore, our study confirms that the use of a method based on digital volume pulse waves (such as the PulseTrace device) is not appropriate for measuring aortic PWV in clinical practice. The SI derived from the PulseTrace measurement is believed to be dependent on wave reflection, which in turn is a function of not only PWV, but also vascular tone and ventricular ejection.
In conclusion, this study confirms the reliability of methods based on the delay between carotid and femoral pressure pulses in estimating aortic PWV (PulsePen and Complior devices). On the contrary, the SI determined by the PulseTrace device cannot be successfully employed for the same purpose. The significant data dispersion and the very weak correlation of PulseTrace data versus the reference method as well as the Complior and PulsePen data, together with the uncertain physiological and hemodynamic principles, suggest against the use of PulseTrace as an analogous system to carotidfemoral PWV.
This study also shows that it is not possible to define absolute reference values for PWV and, therefore, it is necessary to define reference values for each device. More importantly, it would appear imperative in the future to homogenize the algorithms for these different devices to obtain similar PWV values. 
